Similar articles

• Pharmacokinetics of arginine and aspartic acid administered simultaneously in the rat: II. Tissue distribution.

  Campistron G, Guiraud R, Cros J, Prat G. Campistron G, et al. Eur J Drug Metab Pharmacokinet. 1982 Oct-Dec;7(4):315-22. doi: 10.1007/BF03189635. Eur J Drug Metab Pharmacokinet. 1982. PMID: 7166183
• Pharmacokinetics of arginine and aspartic acid administered simultaneously in the rat--III: Changes in the levels of amino acids in the plasma, liver and brain after simultaneous administration of arginine and aspartic acid.

  Campistron G, Guiraud R, Cros J, Pontagnier H. Campistron G, et al. Eur J Drug Metab Pharmacokinet. 1983 Jul-Sep;8(3):281-6. doi: 10.1007/BF03188758. Eur J Drug Metab Pharmacokinet. 1983. PMID: 6653618
• Comparative physiological disposition of N-(phosphonacetyl)-L-aspartate in several animal species after intravenous and oral administration.

  Chadwick M, Silveira DM, MacGregor JA, Branfman AR, Liss RH, Yesair DW. Chadwick M, et al. Cancer Res. 1982 Feb;42(2):627-32. Cancer Res. 1982. PMID: 7055806
• [Study of the fixation and metabolism of arginine aspartate by the radioisotope method].

  Blanquet P, Laparra J. Blanquet P, et al. Sem Hop. 1968 Apr 8;44(17):1161-3. Sem Hop. 1968. PMID: 4299421 French. No abstract available.
• Plasma aspartate levels in rats following administration of monopotassium aspartate via three routes.

  Itoh H, Kishi T, Iwasawa Y, Kawashima K, Chibata I. Itoh H, et al. J Toxicol Sci. 1979 Nov;4(4):377-88. doi: 10.2131/jts.4.377. J Toxicol Sci. 1979. PMID: 548586